We are live on ! Find out more
SFM

Systematic Financial Management Portfolio holdings

AUM $4.36B
1-Year Est. Return 40.56%
This Fund
S&P 500
This Quarter Est. Return
+0.7%
1 Year Est. Return
+40.56%
3 Year Est. Return
+82.4%
5 Year Est. Return
+101.84%
10 Year Est. Return
+456.43%
AUM
$3.93B
AUM Growth
+$3.22M
Cap. Flow
+$53.8M
Cap. Flow %
1.37%
Top 10 Hldgs %
15.41%
Holding
340
New
4
Increased
144
Reduced
56
Closed
89

Sector Composition

Rank Sector Weight
1 Financials 21.42%
2 Industrials 17.46%
3 Technology 14.12%
4 Consumer Discretionary 13.53%
5 Healthcare 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGO icon
76
AngioDynamics
ANGO
$605M
$23.1M 0.59%
2,521,065
+110,719
+5% +$814K
ADC icon
77
Agree Realty
ADC
$9.66B
$23.1M 0.59%
327,760
+14,016
+4% +$1.04M
MKSI icon
78
MKS Inc
MKSI
$17.4B
$22.9M 0.58%
219,678
+20,845
+10% +$2.25M
FCBC icon
79
First Community Bankshares
FCBC
$899M
$22.6M 0.58%
542,599
+10,855
+2% +$478K
AZTA icon
80
Azenta
AZTA
$1.3B
$22.2M 0.57%
444,521
+9,924
+2% +$452K
HAYW icon
81
Hayward Holdings
HAYW
$3.23B
$22.2M 0.57%
1,451,878
+54,813
+4% +$858K
EFOR
82
Everforth Inc
EFOR
$960M
$21.4M 0.54%
256,228
-9,869
-4% -$901K
GENC icon
83
Gencor Industries
GENC
$212M
$20.8M 0.53%
1,178,065
+28,732
+2% +$593K
SHOO icon
84
Steven Madden
SHOO
$3.17B
$20.6M 0.52%
485,056
+45,930
+10% +$2.07M
MCFT icon
85
MasterCraft Boat Holdings
MCFT
$596M
$20.4M 0.52%
1,071,424
+42,839
+4% +$819K
KRG icon
86
Kite Realty
KRG
$5.86B
$20.1M 0.51%
794,687
+30,272
+4% +$796K
CHCT
87
Community Healthcare Trust
CHCT
$536M
$19.9M 0.51%
1,035,836
+99,083
+11% +$1.8M
AUB icon
88
Atlantic Union Bankshares
AUB
$6.05B
$19.9M 0.51%
524,465
+61,426
+13% +$2.43M
IART icon
89
Integra LifeSciences
IART
$1.28B
$19.5M 0.5%
860,563
+248,817
+41% +$5.43M
VVX icon
90
V2X
VVX
$2.7B
$19.2M 0.49%
401,346
+225
+0.1% +$13.4K
GEF icon
91
Greif
GEF
$4.95B
$19M 0.48%
310,236
+7,684
+3% +$502K
NMRK icon
92
Newmark Group
NMRK
$2.64B
$18.9M 0.48%
1,476,123
+54,138
+4% +$800K
OLED icon
93
Universal Display
OLED
$3.75B
$18.8M 0.48%
128,357
+2,266
+2% +$404K
HP icon
94
Helmerich & Payne
HP
$3.34B
$18.4M 0.47%
573,271
+20,770
+4% +$705K
CCRN
95
DELISTED
Cross Country Healthcare
CCRN
$18M 0.46%
988,951
-673,779
-41% -$9.07M
KALU icon
96
Kaiser Aluminum
KALU
$2.48B
$17.9M 0.46%
255,180
+20,263
+9% +$1.54M
SDRL icon
97
Seadrill
SDRL
$2.59B
$17.6M 0.45%
451,265
+73,546
+19% +$2.85M
OCFC icon
98
OceanFirst Financial
OCFC
$1.71B
$17.5M 0.44%
964,646
+47,561
+5% +$908K
INMD icon
99
InMode
INMD
$871M
$17.1M 0.44%
1,026,823
+44,712
+5% +$793K
BNL icon
100
Broadstone Net Lease
BNL
$4.25B
$17M 0.43%
1,069,837
+322,131
+43% +$5.61M

Similar funds

Systematic Financial Management's Q4 2024 Portfolio in Review

As of Q4 2024, Systematic Financial Management held 340 positions worth $3.93B, up 0.08% from $3.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Systematic Financial Management's Q4 2024 filing shows 4 new, 144 increased, 56 reduced and 89 closed positions. Its largest new stake was Amphastar Pharmaceuticals: 246,348 shares worth $9.15M. The largest sale was Qorvo, an estimated $15.2M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.

  • Systematic Financial Management's largest Q4 2024 buy was Amphastar Pharmaceuticals: 246,348 shares worth $9.15M.
  • Systematic Financial Management added most to Jazz Pharmaceuticals in Q4 2024, an estimated $10.9M increase.
  • Systematic Financial Management's biggest Q4 2024 reduction was Qorvo, cutting an estimated $15.2M.
  • Systematic Financial Management fully exited Dana Inc in Q4 2024, selling an estimated $3.52M.
  • Systematic Financial Management's ten largest holdings make up 15% of its $3.93B portfolio in Q4 2024.
  • Systematic Financial Management opened 4 new positions and closed 89 in Q4 2024.
  • Systematic Financial Management's portfolio value rose 0.08% quarter-over-quarter to $3.93B.

Based on Systematic Financial Management's 13F filing for Q4 2024, filed 14 Feb 2025.